1. Home
  2. LESL vs AKTX Comparison

LESL vs AKTX Comparison

Compare LESL & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leslie's Inc.

LESL

Leslie's Inc.

HOLD

Current Price

$9.70

Market Cap

17.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

HOLD

Current Price

$10.02

Market Cap

17.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LESL
AKTX
Founded
1963
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
17.2M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
LESL
AKTX
Price
$9.70
$10.02
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
$2.54
$33.50
AVG Volume (30 Days)
496.3K
179.4K
Earning Date
05-18-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,241,915,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.12
52 Week High
$10.48
$29.32

Technical Indicators

Market Signals
Indicator
LESL
AKTX
Relative Strength Index (RSI) 71.48 45.96
Support Level $0.99 $0.32
Resistance Level N/A $29.32
Average True Range (ATR) 1.54 1.49
MACD 0.10 -0.80
Stochastic Oscillator 86.54 17.06

Price Performance

Historical Comparison
LESL
AKTX

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products, including chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company serves residential pool, residential spa, professional pool, and commercial pool consumers and markets its products through over 1,000 company-operated locations in 39 states and e-commerce websites, operating only in the United States. It operates mainly in the pool and spa aftermarket industry and offers regularly purchased, non-discretionary maintenance items, along with installation and repair services for pool and spa equipment.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

Share on Social Networks: